Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

apoA-I Inibitori

ApoA-I inhibitors are compounds that belong to a chemical class designed to interact with and modulate the activity of apolipoprotein A-I (apoA-I). ApoA-I is a protein that plays a crucial role in lipid metabolism and transport, particularly in the formation of high-density lipoproteins (HDL) or good cholesterol. These inhibitors are developed to target the binding sites or interactions of apoA-I with lipids and other proteins involved in lipoprotein assembly and function.

By targeting apoA-I, these inhibitors provide a means to explore the intricate processes of HDL formation and cholesterol transport within the body. ApoA-I inhibitors enable researchers to investigate how modulating apoA-I's interactions with lipids influences the assembly, stability, and functionality of HDL particles. Additionally, studying the effects of apoA-I inhibitors may offer insights into their roles in cardiovascular health, lipid disorders, and other related conditions. Overall, apoA-I inhibitors serve as valuable tools for unraveling the complex interplay of proteins and lipids in maintaining lipid homeostasis and overall metabolic balance.

VEDI ANCHE...

Nome del prodottoCAS #Codice del prodottoQuantitàPrezzoCITAZIONIValutazione

Anacetrapib

875446-37-0sc-364404
sc-364404A
10 mg
50 mg
$615.00
$1785.00
(0)

Inibitore della CETP che modula i livelli di ApoA-I e il relativo metabolismo lipidico.

Dalcetrapib

211513-37-0sc-364479
sc-364479A
10 mg
50 mg
$720.00
$1900.00
(0)

Inibitore della CETP che influisce sui livelli di ApoA-I e sul metabolismo lipidico.

RVX 208

1044870-39-4sc-472700
10 mg
$340.00
(0)

Aumenta la trascrizione di ApoA-I attraverso l'inibizione della bromodomina BET.